Company / Shares Outstanding
Monte Rosa Therapeutics, Inc. Shares Outstanding History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
73.9M
FY2024
5-year range
1.5M / 73.9M
FY2020-FY2024
Trend
+43.8%
vs FY2023
Sector context
#125 of 212
Health Care
What the data says
At 73910026.00, Monte Rosa Therapeutics, Inc.'s shares outstanding ranks #88 of 212 in the Health Care sector. Shares Outstanding has increased for 4 consecutive years, from 1516912.00 in FY2020 to 73910026.00 in FY2024.
Based on SEC 10-K filings.
73910026.00 in FY2024 with a 3-year CAGR of +43.5%.
Increased from 47227370.00 to 73910026.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +43.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#88 of 212 in Health CareTop 41% of 212This company 73.9M Sector average 306.7M
▼
-75.9% below sector average
Key checks
Key Insights
- Monte Rosa Therapeutics, Inc.'s shares outstanding has grown for 4 consecutive years.
- In FY2024, shares outstanding increased 43.8% year-over-year.
- Ranks #125 out of 212 companies in the Health Care sector.
- Lowest shares outstanding in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | 73.9M | +43.8% |
| FY2023 | 51.4M | +8.8% |
| FY2022 | 47.2M | +88.9% |
| FY2021 | 25.0M | +1548.1% |
| FY2020 | 1.5M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026